Loqmane Seridi

745 total citations
20 papers, 455 citations indexed

About

Loqmane Seridi is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Loqmane Seridi has authored 20 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Rheumatology and 6 papers in Immunology. Recurrent topics in Loqmane Seridi's work include Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Genomics and Phylogenetic Studies (4 papers). Loqmane Seridi is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Genomics and Phylogenetic Studies (4 papers). Loqmane Seridi collaborates with scholars based in United States, Saudi Arabia and Germany. Loqmane Seridi's co-authors include Timothy Ravasi, Taewoo Ryu, Lucas Moitinho‐Silva, Ute Hentschel, Yanal Ghosheh, Taewoo Ryu, Carlo Vittorio Cannistraci, Emily C. Giles, Kristina Bayer and Michael L. Berumen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nature Climate Change.

In The Last Decade

Loqmane Seridi

19 papers receiving 450 citations

Peers

Loqmane Seridi
Jade Carter United States
Leah M. Williams United States
Jun Gu China
Steve Benson United States
Eun Hwa Choi South Korea
Federico Gaiti Australia
Jade Carter United States
Loqmane Seridi
Citations per year, relative to Loqmane Seridi Loqmane Seridi (= 1×) peers Jade Carter

Countries citing papers authored by Loqmane Seridi

Since Specialization
Citations

This map shows the geographic impact of Loqmane Seridi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loqmane Seridi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loqmane Seridi more than expected).

Fields of papers citing papers by Loqmane Seridi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loqmane Seridi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loqmane Seridi. The network helps show where Loqmane Seridi may publish in the future.

Co-authorship network of co-authors of Loqmane Seridi

This figure shows the co-authorship network connecting the top 25 collaborators of Loqmane Seridi. A scholar is included among the top collaborators of Loqmane Seridi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loqmane Seridi. Loqmane Seridi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siebert, Stefan, Laura C. Coates, Georg Schett, et al.. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Arthritis & Rheumatology. 76(6). 894–904. 4 indexed citations
2.
Siebert, Stefan, Kristen Sweet, Christopher T. Ritchlin, et al.. (2023). Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials. ACR Open Rheumatology. 5(9). 490–498. 2 indexed citations
3.
Vollenhoven, Ronald van, Kenneth Kalunian, Thomas Dörner, et al.. (2022). Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 81(11). 1556–1563. 46 indexed citations
4.
Seridi, Loqmane, Matteo Cesaroni, Ashley Orillion, et al.. (2021). Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. Lupus. 30(5). 795–806. 3 indexed citations
5.
Jordan, Jarrat, Jacqueline Benson, W. Winn Chatham, et al.. (2020). First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial. The Lancet Rheumatology. 2(10). e613–e622. 10 indexed citations
6.
Seridi, Loqmane, Matteo Cesaroni, Matthew J. Loza, et al.. (2020). OP0161 ASSOCIATION OF BASELINE CYTOTOXIC GENE EXPRESSION WITH USTEKINUMAB RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 79. 101–102. 2 indexed citations
7.
Cesaroni, Matteo, Loqmane Seridi, Matthew J. Loza, et al.. (2020). Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus. Arthritis & Rheumatology. 73(3). 472–477. 22 indexed citations
8.
Shuaib, Muhammad, Krishna Mohan Parsi, Manjula Thimma, et al.. (2019). Nuclear AGO1 Regulates Gene Expression by Affecting Chromatin Architecture in Human Cells. Cell Systems. 9(5). 446–458.e6. 20 indexed citations
9.
Cesaroni, Matteo, Loqmane Seridi, Jarrat Jordan, et al.. (2019). OP0278 BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 78. 220–221. 1 indexed citations
10.
Jordan, Jarrat, Kristen Sweet, Matteo Cesaroni, et al.. (2019). 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus. Abstracts. A185.1–A185.
11.
Seridi, Loqmane, Gregory C. Leo, G. Lynis Dohm, Walter J. Pories, & James M. Lenhard. (2018). Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome. PLoS ONE. 13(5). e0198156–e0198156. 15 indexed citations
12.
Ghosheh, Yanal, Loqmane Seridi, Taewoo Ryu, et al.. (2016). Characterization of piRNAs across postnatal development in mouse brain. Scientific Reports. 6(1). 25039–25039. 30 indexed citations
13.
Chandramouli, Kondethimmanahalli, Taewoo Ryu, Huoming Zhang, et al.. (2015). Transcriptome and proteome dynamics in larvae of the barnacle Balanus Amphitrite from the Red Sea. BMC Genomics. 16(1). 1063–1063. 13 indexed citations
14.
Veilleux, Heather D., Taewoo Ryu, Jennifer M. Donelson, et al.. (2015). Molecular processes of transgenerational acclimation to a warming ocean. Nature Climate Change. 5(12). 1074–1078. 95 indexed citations
15.
Wong, Yue Him, Taewoo Ryu, Loqmane Seridi, et al.. (2014). Transcriptome analysis elucidates key developmental components of bryozoan lophophore development. Scientific Reports. 4(1). 6534–6534. 17 indexed citations
16.
Seridi, Loqmane, Taewoo Ryu, & Timothy Ravasi. (2014). Dynamic Epigenetic Control of Highly Conserved Noncoding Elements. PLoS ONE. 9(10). e109326–e109326. 3 indexed citations
17.
Moitinho‐Silva, Lucas, Loqmane Seridi, Taewoo Ryu, et al.. (2014). Revealing microbial functional activities in the R ed S ea sponge S tylissa carteri by metatranscriptomics. Environmental Microbiology. 16(12). 3683–3698. 49 indexed citations
18.
Moitinho‐Silva, Lucas, Kristina Bayer, Carlo Vittorio Cannistraci, et al.. (2013). Specificity and transcriptional activity of microbiota associated with low and high microbial abundance sponges from the Red Sea. Molecular Ecology. 23(6). 1348–1363. 98 indexed citations
19.
Ryu, Taewoo, Loqmane Seridi, & Timothy Ravasi. (2012). The evolution of ultraconserved elements with different phylogenetic origins. BMC Evolutionary Biology. 12(1). 236–236. 22 indexed citations
20.
Salem, Saeed, et al.. (2011). CLARM. King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology). 646–650. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026